SPECIAL LOCATION: FOLEY HOAG LLP, Seaport West,155 Seaport Boulevard, Boston
For Driving and Parking Information, Click Here.
We are pleased to announce that our 6th Annual Summer Social Networking Event will be returning on August 1st. We are currently accepting applications here. For those of you that have never attended one of these, they are typically one of our most well-attended events of the year, with health innovation professionals from all backgrounds coming to see what’s new and exciting in the local biotech, medtech, pharma and health IT economy.
Please feel free to preregister now if you plan to attend. And if you want to pitch, take 5 minutes to fill in this application by July 22nd. We will typically let you know within a few days if you have been selected to participate so you can begin work on your slide. The order of registration for pitching companies will be the order of your presentations given.
We also have two venture capitalists as keynote speakers. Register now to attend this exciting event!
This is the NEHEN event of the year that you don’t want to miss!
Carl M Berke, PhD, Partner, Partners HealthCare Innovation Fund
Carl is a Partner at Partners HealthCare Innovation Fund in Cambridge, investing in new biomedical technologies emerging from Massachusetts General Hospital and Brigham & Womens Hospital. He is also currently a Founding Director of Mass Medical Angels LLC, a local investment group dedicated to seed stage investment in biomedical innovation. His career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical diagnostic products – he is an inventor on 6 US patents. He served as a Partner at Integral/Analysis Group, a management consultancy focused on innovation and growth strategy. He has served on the boards of Quosa [literature access software], Kasalis [robotics], Annovation [novel anesthetics], Combinent [drug delivery], Sebacia [acne treatment], Infobionic [cardiac monitoring], QPID Health [bioinformatics], LifeImage [diagnostic image sharing], Syntimmune [autoimmune therapy], Argo Cardiovascular and the Sudanese Education Fund [philanthropy]. Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the in the Harvard-MIT Health Sciences and Technology Division.
Send this to friend